Literature DB >> 32176400

Chronic Hepatitis B infection and the risk of gestational diabetes: a cross sectional study.

Michelle Giles1,2, Mary-Ann Davey1, Euan Wallace1.   

Abstract

OBJECTIVE: An estimated two billion people worldwide live with hepatitis B virus (HBV) infection. Many of these are women of reproductive age. Studies that have examined pregnancy outcomes in women living with HBV have reported conflicting results in relation to the incidence of gestational diabetes (GDM). The aim of this study is to examine if gestational diabetes is more common in women with chronic HBV residing in a non-Asian country
DESIGN: Cross sectional study
SETTING: Victoria, Australia POPULATION: All singleton births between 2009 and 2017
METHODS: Poisson regression was performed to determine if gestational diabetes is more common in women with HBV compared to women without HBV taking into account other risk factors such as maternal age, body mass index, parity, and country of birth. MAIN OUTCOME MEASURE: Gestational diabetes diagnosis in women with chronic HBV infection
RESULTS: For women with HBV, the unadjusted incidence risk ratio for GDM was 1.75 (95% CI 1.6, 1.9). After adjusting for region of birth, BMI, parity, age and smoking, the adjusted incidence risk ratio was 1.2 (95% CI 1.1, 1.3) The highest incidence (37.1%) of GDM was in women with HBV and a BMI of >40.
CONCLUSIONS: The findings from this study confirm an association between HBV and GDM. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  gestational diabetes; hepatitis B virus; pregnancy

Year:  2020        PMID: 32176400     DOI: 10.1111/1471-0528.16217

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  2 in total

1.  The Neuropeptide-Related HERC5/TAC1 Interactions May Be Associated with the Dysregulation of lncRNA GAS5 Expression in Gestational Diabetes Mellitus Exosomes.

Authors:  Gui-Yan Tang; Ping Yu; Chen Zhang; Hong-Yu Deng; Mei-Xiu Lu; Jiang-Hua Le
Journal:  Dis Markers       Date:  2022-02-08       Impact factor: 3.434

2.  Maternal hepatitis B surface antigen Carrier Status and Pregnancy Outcome: A Retrospective Cohort Study.

Authors:  Yiming Chen; Wenwen Ning; Xue Wang; Yijie Chen; Bin Wu; Jie Tao
Journal:  Epidemiol Infect       Date:  2022-04-20       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.